APA aipamena

Kaliszewski, K., Diakowska, D., Wojtczak, B., Sutkowski, K., Knychalski, B., & Forkasiewicz, Z. (2019). Patients with III and IV category of the Bethesda System under levothyroxine non-suppressive therapy have a lower rate of thyroid malignancy. Sci Rep.

Chicago Style aipamena

Kaliszewski, Krzysztof, Dorota Diakowska, Beata Wojtczak, Krzysztof Sutkowski, Bartłomiej Knychalski, and Zdzisław Forkasiewicz. "Patients With III and IV Category of the Bethesda System Under Levothyroxine Non-suppressive Therapy Have a Lower Rate of Thyroid Malignancy." Sci Rep 2019.

MLA aipamena

Kaliszewski, Krzysztof, et al. "Patients With III and IV Category of the Bethesda System Under Levothyroxine Non-suppressive Therapy Have a Lower Rate of Thyroid Malignancy." Sci Rep 2019.